Financials
- Fiscal year
- 2024
- Total assets
- €116,345
- Loss
- -€101,688
- Solvency
- -352.8%
Total assets▼ 41.8%
Net result
20182024
BroerBroer
ActiveSummary
The computed 12-month bankruptcy probability of BroerBroer is 2.6% (moderate). The 2024 annual accounts show negative equity (-€410,419) and a net result of -€101,688. Equity is shrinking by ~14.8% per year across the filed fiscal years. Its solvency ranks better than 5% of 9085 sector peers (fiscal year 2024). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.
Overview
Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€116,345total assets 2024
- Equity
- -€410,419
- Loss
- -€101,688
Turnover not published (abridged schema)
Structure
Accounts 63 d overdue0 of 5 deeds read
Why 49- Loss of €101,688, the second in a row (FY 2024)- Figures for FY 2024 (filed 23-07-2025)+ Size: total assets €116,345+ Founded in 2011Show the evidence
Checked score
Score 2024
49
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 9% of its sector peers (NACE 46, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Weak
Solvency
0=
equity -352.8% of total assets
Liquidity
11+4
short-term debt 326.3% · cash 9.0%
Profitability
0=
return on assets -87.4%
Bankruptcy probability, 12 months
2.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 9 months
02-2026: 1.7%
03-2026: 1.6%▼ -3.6% vs 02-2026
04-2026: 1.6%● 0.0% vs 03-2026
05-2026: 1.6%▼ -3.2% vs 04-2026
06-2026: 1.5%▼ -3.2% vs 05-2026lowest value
07-2026: 1.6%▲ +5.5% vs 06-2026
08-2026: 2.2%▲ +34.8% vs 07-2026
09-2026: 2.3%▲ +5.3% vs 08-2026
10-2026: 2.6%▲ +11.7% vs 09-2026highest value
- Size: total assets €116,345 lowers the probability for this profile
- Loss of €101,688, the second in a row (FY 2024) raises the probability
- Figures for FY 2024 (filed 23-07-2025) raises the probability
- Founded in 2011 lowers the probability for this profile
No credit on open account
Liquidity short (current ratio 0.21 against 0.42 in 2023; short-term debt: 326.3% and cash: 9% of total assets), and equity is negative.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, micro). Better than this share of them on solvency 6%, liquidity 12%, profitability 6%, growth against the median 14%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year -€410,419
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-07-2025, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
8 d early
2023
21 d late
2022
16 d late
2021
29 d late
2020
31 d late
2019
91 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 30 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · abbreviated…
- Weakest financial yearnet -€101,688
- Annual accounts filedfiscal year 2023 · abbreviated…
Key points
- Risk: Negative equityfiscal year 2024: debts exceed assets -€410,419 View
- Risk: 7 loss-making years in a rowloss fiscal year 2024 -€101,688 View
- Caution: Among the weakest 5% on solvencysector median 44.1% · 9,085 companies -352.8% View
- Caution: Accounts not fileddeadline was 31-07-2026 63 d late View
- Caution: Equity fell in 2024from -€308,731 to -€410,419 ▼ 32.9% View
By topic
Timeline
- Events
- 11
- Since
- 2016
- 23-07-2025Annual accounts filed
- 31-12-2024Weakest financial year
- 21-08-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Founded
- 29-06-2011
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.